Cargando…
The Present Status of Immuno-Oncolytic Viruses in the Treatment of Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC) is the fifth leading cause of cancer-related death in Western countries. The incidence of PDAC has increased over the last 40 years and is projected to be the second leading cause of cancer death by 2030. Despite aggressive treatment regimens, prognosis for pa...
Autores principales: | Haller, Scott D., Monaco, Michael L., Essani, Karim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698570/ https://www.ncbi.nlm.nih.gov/pubmed/33213031 http://dx.doi.org/10.3390/v12111318 |
Ejemplares similares
-
Triple-Negative Breast Cancer: Basic Biology and Immuno-Oncolytic Viruses
por: Monaco, Michael L., et al.
Publicado: (2023) -
Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic Applications
por: Uusi-Kerttula, Hanni, et al.
Publicado: (2015) -
Multiple Administration Routes, Including Intramuscular Injection, of Oncolytic Tanapoxvirus Variants Significantly Regress Human Melanoma Xenografts in BALB/c Nude Mice Reconstituted with Splenocytes from Normal BALB/c Donors
por: Monaco, Michael L., et al.
Publicado: (2023) -
Oncolytic Viruses for Canine Cancer Treatment
por: Sánchez, Diana, et al.
Publicado: (2018) -
The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers
por: Eissa, Ibrahim Ragab, et al.
Publicado: (2018)